| Financial Year |
March 31 2023 |
| Monetary Funds |
3,294,825,713.21 |
| Held-for-trading Financial Assets |
6,000,000.00 |
| Notes Receivable |
15,801,537.80 |
| Accounts Receivable |
2,660,989,086.40 |
| Advances to Suppliers |
133,353,633.41 |
| Other Receivables |
51,013,674.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,721,424,164.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
219,890,450.88 |
| Total Current Assets |
8,111,059,020.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,638,078.09 |
| Investment Properties |
8,980,298.99 |
| Fixed Assetes |
1,813,996,700.61 |
| Under-construction Projects |
319,191,032.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
227,444,491.13 |
| R&D expenses |
-- |
| Goodwill |
94,866,025.56 |
| Long-Term Deferred and Prepaid Expenses |
29,769,407.18 |
| Deferred Income Tax Assets |
80,261,989.71 |
| Other Non-Current Assets |
116,865,998.62 |
| Sub-Total of Non-Current Assets |
2,708,579,605.70 |
| Total Assets |
10,819,638,626.46 |
| Short-Term Loans |
666,262,377.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,413,359,439.16 |
| Accounts Payable |
668,845,757.72 |
| Accounts Received In Advance |
2,249,441.47 |
| Employee Compensation Payable |
133,233,737.36 |
| Taxes Payable |
91,639,650.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,036,237.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,392,363.00 |
| Other Current Liabilities |
18,044,888.76 |
| Sub-Total of Current Liabilities |
4,160,260,673.98 |
| Long-term Loans |
13,213,253.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
56,583,458.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
90,736,673.80 |
| Total Liabilities |
4,250,997,347.78 |
| Paid-In Capital(Or Share Stock) |
277,115,744.00 |
| Capital Surplus |
2,313,713,150.92 |
| Surplus Reserve |
158,674,657.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,604,622,469.54 |
| Minority Stockholder's Interest |
205,921,348.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,362,719,929.70 |
| Owner's Equity（Stockholder's Equity） |
6,568,641,278.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,819,638,626.46 |
